Expected earnings - 4D Molecular Therapeutics Inc.
Source: US Earnings Reports
4D Molecular Therapeutics Inc. (FDMT) is expected to report $-0.88 for Q2 2025
4D Molecular Therapeutics Inc.
NASDAQ: FDMT
FDMT Trading
-1.66% G/L:
$8.27 Last:
104,610 Volume:
$8.35 Open:
FDMT Latest News
FDMT Stock Data
$519,643,507
47,993,463
N/A
51
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
